Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11

Yunfei Liao; Slim Sassi; Stefan Halvorsen; Yong Feng; Jacson Shen; Yan Gao; Gregory Cote; Edwin Choy; David Harmon; Henry Mankin; Francis Hornicek; Zhenfeng Duan

doi:10.1038/s41598-018-30644-x

Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11

Sci Rep. 2018 Aug 9;8(1):12107. doi: 10.1038/s41598-018-30644-x.

Authors

Yunfei Liao^{1

2}, Slim Sassi^{1

3}, Stefan Halvorsen³, Yong Feng^{1

4}, Jacson Shen¹, Yan Gao¹, Gregory Cote⁵, Edwin Choy⁵, David Harmon⁵, Henry Mankin¹, Francis Hornicek¹, Zhenfeng Duan⁶

Affiliations

¹ Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Jackson 1115, Boston, Massachusetts, 02114, USA.
² Department of Endocrinology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jie Fang Avenue, Wuhan, 430022, China.
³ Center for Computational and Integrative Biology (CCIB), Massachusetts General Hospital, Boston, Massachusetts, 02139, USA.
⁴ Department of Orthopaedic Surgery, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jie Fang Avenue, Wuhan, 430022, China.
⁵ Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, 02114, USA.
⁶ Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Jackson 1115, Boston, Massachusetts, 02114, USA. zduan@mgh.harvard.edu.

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Publication types

Published Erratum